PMEF
SRNE

Point72 Middle East FZE’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Point72 Middle East FZE’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-130,765
Closed -$116K – 1812
2022
Q4 		$116K Buy
+130,765
New +$116K 0.01% 711